Juul Labs, Inc., Washington, DC, USA.
Pinney Associates, Inc., Pittsburgh, PA, USA.
Nicotine Tob Res. 2021 Nov 5;23(12):2153-2161. doi: 10.1093/ntr/ntab134.
Evidence suggests that cigarette smokers who switch to electronic nicotine delivery systems (ENDS) reduce their exposure to harmful toxicants and carcinogens. It is unclear if dual-use is associated with decreases in exposure to toxicants.
This parallel-group confinement study assessed changes in biomarkers of exposure (BOEs) over six days among healthy adult smokers who were randomized into 1 of 11 study groups: eight JUUL-brand System (JUUL) groups (4 JUUL flavors [Virginia Tobacco, Menthol, Mint, Mango] × 2 nicotine concentrations [5.0% or 3.0% by weight]); Dual-Use group used preferred JUUL flavor (5.0% nicotine) and ≤50% usual brand (UB) cigarettes/day; UB Cigarette group and one group abstained from all tobacco/nicotine product use (Abstinence group). Urine and blood analysis assessed changes in primary BOE endpoints (NNAL, 3-HPMA, MHBMA, S-PMA COHb) and secondary BOE endpoints (NNN, HMPMA, CEMA, 1-OHP, O-toluidine, 2-NA, 4-ABP) among 279 adult smokers.
In JUUL groups, median percent reductions in primary BOEs (Day 6-Baseline) were 90%-≥100% of Abstinence; there were no significant differences between JUUL groups and Abstinence. All reductions in JUUL groups were substantially and statistically significantly greater than reductions in the UB Cigarette group (ps < 0.025). Median reductions in primary BOEs in the Dual-Use group were 43%-55% of Abstinence. Similar results were observed for secondary BOEs.
This study suggests that the use of JUUL as a complete or partial substitute (i.e., dual-use with ≥50% reduction in cigarette consumption) for combustible cigarettes can substantially reduce exposure to multiple toxins associated with cigarette smoking.
This study adds to the growing body of evidence supporting the utility of ENDS products as potentially reduced-harm alternatives to cigarettes for adult smokers. Adult smokers who switched completely from cigarette smoking to use of the JUUL System ("JUUL") in two nicotine concentrations (5.0% and 3.0%) and four flavors significantly reduced their exposure to multiple classes of cigarette-related toxicants. Additionally, smokers who used JUUL and continued smoking but reduced their daily cigarette consumption by ≥50% (dual users) also significantly reduced their toxicant exposure compared to cigarette smoking.
有证据表明,将香烟换成电子尼古丁传送系统(ENDS)的烟民会减少接触有害有毒物质和致癌物质。目前尚不清楚双重使用是否会降低接触有毒物质的风险。
这项平行组限制研究评估了健康成年吸烟者在六天内的暴露生物标志物(BOEs)变化,这些吸烟者被随机分配到 11 个研究组之一:8 个 JUUL 品牌系统(JUUL)组(4 种 JUUL 口味[弗吉尼亚烟草、薄荷、薄荷、芒果]×2 种尼古丁浓度[5.0%或 3.0%重量]);双重使用组使用首选的 JUUL 口味(5.0%尼古丁)和≤50%惯用品牌(UB)香烟/天;UB 香烟组和一组禁止使用所有烟草/尼古丁产品(禁欲组)。尿液和血液分析评估了 279 名成年吸烟者主要暴露生物标志物终点(NNAL、3-HPMA、MHBMA、S-PMA COHb)和次要暴露生物标志物终点(NNN、HMPMA、CEMA、1-OHP、O-甲苯胺、2-NA、4-ABP)的变化。
在 JUUL 组中,主要暴露生物标志物终点(第 6 天-基线)的中位数百分比降低为 90%-≥100%的禁欲;JUUL 组之间没有显著差异与禁欲组。JUUL 组的所有降低都大大超过 UB 香烟组(p < 0.025)。双重使用组中主要暴露生物标志物终点的中位数降低了 43%-55%的禁欲。次要暴露生物标志物终点也观察到类似的结果。
本研究表明,JUUL 作为可燃香烟的完全或部分替代品(即,使用量减少≥50%)的使用可以大大减少与吸烟相关的多种毒素的暴露。
这项研究增加了越来越多的证据,支持 ENDS 产品作为成人吸烟者潜在的降低危害的香烟替代品的效用。完全从香烟吸烟转为使用两种尼古丁浓度(5.0%和 3.0%)和四种口味的 JUUL 系统(“JUUL”)的成年吸烟者显著降低了他们对多类香烟相关有毒物质的接触。此外,与吸烟相比,使用 JUUL 并继续吸烟但每天减少吸烟量≥50%的吸烟者(双重使用者)也显著降低了他们的有毒物质暴露。